Thrive 210: Cancer DNA Panel
Any disease specifically cancer needs to be diagnosed early so that the relevant precautionary measures can be taken. Thrive 210 offers a cancer DNA panel that provides the high value service of early detection of cancer by analyzing the DNA fragments circulating in your bloodstream.
This screening evaluates methylation patterns and other genomic signals associated with dozens of cancer types—often before symptoms appear or tumors are visible on imaging. This allows for earlier diagnosis, earlier intervention, and improved treatment outcomes.
By combining your medical records, biomarker profile and this genomic insight, our team gets a deeper understanding and clear picture of the cancer risk associated with your health. This test does not serve as a replacement for routine screening such as mammograms or colonoscopies, but it can be used as a powerful adjunct for individuals who want a proactive, preventive approach to long-term health and early disease identification.
Our Services
Book A Consultation
Why Thrive 210?
Our integrative team combines advanced diagnostic tools with medical expertise to provide proactive, prevention-oriented care. The Cancer DNA Panel enhances our comprehensive approach to longevity and early disease detection.
What We Evaluate?
At Thrive 210, we evaluate a number of parameters in our Cancer DNA panel to detect the early symptoms of cancer before they start appearing prominently. Here’s what we evaluate and look into deeply:
• DNA methylation patterns associated with cancer
• Cell-free DNA signals in the bloodstream
• Multi-cancer early detection markers
• Potential tissue or organ of origin (when applicable)
• Integration with personal + family medical history
How This Supports Your Health?
Early cancer detection significantly improves survival outcomes. By identifying cancer associated signals at the molecular level, often before symptoms or imaging findings appear, we can address risk earlier, coordinate follow-up testing, and guide next steps with precision and urgency.
What To Expect?
This is what you can expect from this therapy at Thrive 210:
• Simple blood draw
• Laboratory genomic analysis
• Physician review and interpretation
• Clear guidance on any abnormal findings
• Coordination with specialists if medical follow-up is needed
Schedule your Cancer DNA Panel screening.
Our Specialist
Anglea Carbone
Soft Tissue Therapist
Anglea Carbone
Soft Tissue Therapist